Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 386 results.
LastUpdate Updated on 14/09/2026 [07:19:00]
pdfxls
Solicitudes publicadas en los últimos 30 días / Applications published in the last 30 days
previousPage Results 175 to 200 of 386 nextPage  

PHOTOCURABLE REINFORCEMENT OF 3D PRINTED HYDROGEL OBJECTS

Publication No.:  US20260248919A1 27/08/2026
Applicant: 
LUNG BIOTECHNOLOGY PBC [US]
Lung Biotechnology PBC
US_20260248919_A1

Absstract of: US20260248919A1

The present disclosure provides reinforced hydrogel structures, methods of reinforcing hydrogel structures, and methods of treating ischemic disorders using the reinforced hydrogel structures.

ILLNESS DETECTION BASED ON NERVOUS SYSTEM METRICS

Publication No.:  US20260248462A1 27/08/2026
Applicant: 
OURA HEALTH OY [FI]
Oura Health Oy
US_20260248462_A1

Absstract of: US20260248462A1

Methods, systems, and devices for illness detection are described. A method may include receiving heart rate variability (HRV) data associated with a user from a wearable device, the HRV data collected via the wearable device throughout a first time interval and a second time interval subsequent to the first time interval. The method may include inputting the HRV data into a classifier, and identifying a satisfaction of deviation criteria between a first subset of the HRV data collected throughout the first time interval and a second subset of the HRV data collected throughout the second time interval. The method may include causing a graphical user interface (GUI) of a user device to display an illness risk metric for the user based on the satisfaction of the deviation criteria, the illness risk metric associated with a relative probability that the user will transition from a healthy state to an unhealthy state.

Classification of tumor microenvironments

Publication No.:  AU2026205056A1 27/08/2026
Applicant: 
FENG BIOSCIENCES LTD
Feng Biosciences, Ltd.
AU_2026205056_A1

Absstract of: AU2026205056A1

The disclosure provides population and non-population-based classifiers to categorize patients and cancers. The population-based classifiers disclosed integrate signatures, i.e., global scores related to the expression of genes in particular gene panels. The non-population- based classifiers are generated using machine-learning techniques (e.g., regression, random forests, or ANN). Each type of classifier stratifies patients and cancers according to tumor microenvironments (TME) as biomarker-positive or biomarker-negative, and treatment decisions are then guided by the presence/absence of a particular TME. Also provided are methods for treating a subject, e.g., a human subject, afflicted with cancer comprising administering a particular therapy depending on the classification of the cancer’s TME according to the disclosed classifiers. Also provided are personalized treatments that can be administered to a subject having a cancer classified into a particular TME, and gene panels that can be used for identifying a human subject afflicted with a cancer suitable for treatment with a particular therapeutic agent. un u n

HARDWARE-ACCELERATED NEUROMORPHIC SYSTEM FOR REAL-TIME OUTCOME MONITORING, MULTIMODAL ASSET GOVERNANCE, AND REGULATORY COMPLIANCE FOR TRANSPOSABLE SELF-RELIANT ENTITIES

Publication No.:  US20260254923A1 27/08/2026
Applicant: 
RITCHEY KURTIS JOHN [US]
RITCHEY KENNETH IRA [US]
VIRTUAL VIDEO REALLY BY RITCHEY LLC [US]
VIRTUAL VIDEO REALTY BY RITCHEY LLC [US]
Ritchey Kurtis John
Ritchey Kenneth Ira
Virtual Video Really by Ritchey, LLC
Virtual Video Realty by Ritchey, LLC
US_20260254923_A1

Absstract of: US20260254923A1

A hardware-accelerated neuromorphic system and method are provided for real-time outcome monitoring of transposable transformations within an enterprise environment. The system utilizes a Neuromorphic System-on-Wafer (SoW) architecture comprising a plurality of Synaptic Processing Units (SPU) and AI accelerators to facilitate low-latency processing of neural correlates of consciousness (NCC). A shared synaptic chip interface identifies brain activity in a biological substrate and audits identified neural correlates against stored transformation blueprints and international regulatory standards, such as Wheaton System Engineering Standards, to validate desired transformational outcomes. The system further incorporates multimodal asset governance, where transformational outcomes may be collateralized by labor contracts or physical assets, ensuring identity continuity during distal reconstitution into mechatronic substrates.

CLINICIAN PROGRAMMER WORKFLOW AUTOMATION FOR IMPLANTABLE MEDICAL DEVICES

Publication No.:  AU2025219161A1 27/08/2026
Applicant: 
THE ALFRED E MANN FOUNDATION FOR SCIENT RESEARCH
THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
AU_2025219161_PA

Absstract of: AU2025219161A1

The present disclosure relates to stimulation systems, comprising, e.g., an implantable medical device (IMD), such as an implantable pulse generator configured to deliver electrical stimulation to one or more nerves of a subject, or an implantable pump configured to administer one or more active agents. In some aspects, the IMD is configured to store one or more clinical state parameters (e.g., a clinical workflow stage) and/or to advertise or transmit the stored one or more clinical state parameters to a clinician programmer device. One or more settings of the IMD, and/or parameters of the administration of electrical stimulation or the active agent(s), may be set based on the one or more clinical state parameters (e.g., a clinical workflow stage), e.g., either automatically or based on instructions provided by the clinician programmer device.

MICROENVIRONMENTAL MONITORING UTILIZING DIFFERENT TYPES OF SENSING DEVICES IN A BODY AREA NETWORK ASSOCIATED WITH A SUBJECT

Publication No.:  US20260248389A1 27/08/2026
Applicant: 
LIFELENS TECH INC [US]
LifeLens Technologies, Inc.
US_20260248389_A1

Absstract of: US20260248389A1

0000 An apparatus comprises a processing device implementing a body area network (BAN) controller for a BAN associated with a subject. The processing device is configured to pair first and second sets of sensing devices with the BAN associated with the subject, the first set of sensing devices configured for physiologic monitoring of the subject and the second set of sensing devices configured for contextual monitoring of an environment of the subject. The processing device is also configured to enable data sharing of physiologic monitoring data obtained from the first set of sensing devices and contextual monitoring data obtained from the second set of sensing devices utilizing the BAN associated with the subject, and to determine, based on the physiologic monitoring data obtained from the first set of sensing devices and the contextual monitoring data obtained from the second set of sseennssiinngg devices, microenvironmental monitoring parameters associated with the subject.

COMPUTER-AIDED DIAGNOSIS SYSTEM

Publication No.:  US20260253212A1 27/08/2026
Applicant: 
GYRUS ACMI INC D/B/A OLYMPUS SURGICAL TECH AMERICA [US]
GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
US_20260253212_A1

Absstract of: US20260253212A1

0000 A system for intelligent surveillance of attention and recognition of computer-aided diagnosis system outputs. The system can include an endoscope, a computer-aided diagnostic module, a camera, a memory, and a controller. The endoscope can include an elongated member that can include a distal portion and a process camera attached to the distal portion. The process camera can capture a video stream during a procedure. The computer-aided diagnostic module can be configured to detect an abnormality within the video stream using a diagnostic algorithm and transmit a signal. The controller can be configured to determine a gaze location of the doctor during the procedure using a gaze algorithm, determine whether the doctor looked at the detected abnormality by comparing the signal from the computer-aided diagnostic module and the gaze location of the doctor, and trigger a countermeasure based on determining that the doctor did not look at the detected abnormality.

MACHINE LEARNING FOR OBJECT TRACKING

Publication No.:  US20260248561A1 27/08/2026
Applicant: 
CORNELL UNIV [US]
Cornell University
US_20260248561_A1

Absstract of: US20260248561A1

The present disclosure provides systems and methods capable of determining a roll angle of a medical instrument in real time based on one or more medical images that include the medical instrument. In different versions, the images may be, for example, fluoroscopic, ultrasound, and/or video. The roll angle may be determined using one or more machine learning models. Other degrees of freedom may also be determined. The roll angle (and potentially other degrees of freedom) may be used in visualizations that guide a user of the medical instrument. The visualization may employ various displays and/or headsets, and may be used with an augmented reality (AR) system, a mixed reality (MR) system, a virtual reality (VR) system, an extended reality (XR) system, and/or a spatial computing system.

CLINICAL DATA ANALYSIS

Publication No.:  US20260253729A1 27/08/2026
Applicant: 
SOLVENTUM INTELLECTUAL PROPERTIES COMPANUY [US]
SOLVENTUM INTELLECTUAL PROPERTIES COMPANUY
US_20260253729_A1

Absstract of: US20260253729A1

A method for clinical data analysis includes receiving a first 3D representation that is representative of clinical data. The first three-dimensional (3D) representation includes one or more mesh elements. The method includes computing one or more mesh element features for the one or more mesh elements and providing the one or more mesh element features as an input to a first machine learning (ML) module. The method includes executing the first ML module to encode the first 3D representation into one or more latent representations and providing the one or more latent representations to a second ML module that is different from the first ML module. The method includes executing the second ML module to classify the clinical data represented in the first 3D representation into at least one predicted classification label.

METHODS AND SYSTEMS FOR CHARACTERIZING POROSITY OF ADDITIVELY MANUFACTURED BONE SCAFFOLDS

Publication No.:  US20260253203A1 27/08/2026
Applicant: 
MARSHALL UNIV RESEARCH CORPORATION [US]
MARSHALL UNIVERSITY RESEARCH CORPORATION
US_20260253203_A1

Absstract of: US20260253203A1

A method for characterizing a bone tissue scaffold produced by an additive manufacturing process is provided. An image of the bone tissue scaffold is first captured and a boundary of the bone tissue scaffold is determined. One or more surface features of the bone tissue scaffold are subsequently detected using an edge detection algorithm, with the one or more surface features including one or more pores and/or one or more highlights. Edges that correspond to a pore using a pore filling algorithm are identified and the surface porosity of the bone tissue scaffold is thereby mapped. Systems for characterizing a bone tissue scaffold are also provided and make use of an image capture device for capturing an image of the bone tissue scaffold, as well as a processor for analyzing the image via instructions stored on the processor.

POSITIONER FOR ORTHODONTIC ALIGNER

Publication No.:  WO2026177259A1 27/08/2026
Applicant: 
MAVEN INC [KR]
\uBA54\uC774\uBE10 \uC8FC\uC2DD\uD68C\uC0AC
WO_2026177259_A1

Absstract of: WO2026177259A1

The present invention relates to a positioner for an orthodontic aligner. The positioner comprises a body (120) having a three-dimensional shape, provided with an adhesive surface (126), and having a through-hole (129) formed on one side and passing through in a transverse direction, and is fixed to teeth by attaching the adhesive surface (126) to the teeth. On the basis of teeth arrangement data obtained by scanning in a state in which the body (120) is fixed to the teeth, the positioner can guide the positions for mounting the body (120) attached to the teeth to be corrected and orthodontic means formed to correspond to each of the teeth. Furthermore, by hanging a wire on the through-hole (129) and pushing or pulling the teeth, preliminary correction can be performed prior to correcting the teeth using the orthodontic means.

Polymeric Structures Having a Micro-Void Space and Systems and Methods for Making Same

Publication No.:  US20260249546A1 27/08/2026
Applicant: 
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV [US]
The Board of Trustees of the Leland Stanford Junior University
US_20260249546_A1

Absstract of: US20260249546A1

Aspects of the present disclosure include methods for making a polymeric structure having a micro-void space. Methods according to certain embodiments include irradiating a polymerizable composition positioned between a build elevator and a build surface to generate a polymerizable composition having a polymerized region of the polymerizable composition having a micro-void space in contact with the build elevator and a non-polymerized region of the polymerizable composition in contact with the build surface, displacing the build elevator away from the build surface, contacting the generated micro-void space with a non-reactive composition and repeating in a manner sufficient to generate a polymeric structure having a resolved micro-void space. Systems for preparing a polymeric structure according to the subject methods are also described. Polymeric structures having a resolved micro-void space such as where the micro-void space is filled with a non-polymerizable composition are also provided.

ADDITIVELY MANUFACTURED WIRE PRODUCTS FORMED FROM NICKEL-TITANIUM SHAPE MEMORY ALLOYS

Publication No.:  US20260249356A1 27/08/2026
Applicant: 
FORT WAYNE METALS RES PRODUCTS LLC [US]
Fort Wayne Metals Research Products, LLC
US_20260249356_A1

Absstract of: US20260249356A1

0000 A method of producing a wire product from a nickel-titanium shape memory alloy, and a wire product produced by such method. The method includes consolidating a nickel-titanium shape memory alloy to a preform using an additive manufacturing process. Thereafter, the preform may be subject to a hot working process, including heating the preform and deforming the preform, such as by, forging, extrusion, rolling, swaging, and the like. The hot-worked preform may be annealed following hot working. The preform may then be subjected to one or more cold working processes including drawing, swaging, rolling, and the like. Annealing may also occur after cold working. The hot and cold working processes may impart significant diameter reduction to form the wire product.

CERAMIC SLURRY COMPOSITION FOR PHOTOCURABLE 3D PRINTING

Publication No.:  WO2026177311A1 27/08/2026
Applicant: 
VERICOM CO LTD [KR]
(\uC8FC) \uBCA0\uB9AC\uCF64
WO_2026177311_A1

Absstract of: WO2026177311A1

The present invention relates to a ceramic slurry composition for photocurable 3D printing and, more specifically, to a ceramic slurry composition for photocurable 3D printing, which uses a ceramic or glass-ceramic powder, thereby enabling a dental prosthesis to exhibit esthetics similar to natural teeth, and furthermore, comprises a non-reactive diluent, thereby enabling the preparation of a low-viscosity slurry comprising a high content of ceramic or glass-ceramic powder, and in which the slurry thus prepared is easy to mold using 3D printing, and a high-quality three-dimensional molded article can be manufactured upon 3D printing.

INTELLIGENT DOSING PLATFORM WITH AGENTIC SOCIAL MEDIA INTEGRATION AND PATIENT SUPPORT NETWORK COORDINATION FOR INJECTABLE MEDICATION ADMINISTRATION

Publication No.:  US20260249002A1 27/08/2026
Applicant: 
DATADOSE LLC [US]
DATADOSE, LLC
US_20260249002_A1

Absstract of: US20260249002A1

An intelligent dosing platform incorporating comprehensive social media integration and patient support network capabilities for injectable medication administration. The platform includes social media interface modules configured to facilitate medication-related communications across multiple social platforms, dosage detection modules that automatically trigger social media notifications and support group communications upon medication administration events, and patient network modules that connect patients with support groups and other patients with similar medication regimens. The system features agentic social network modules utilizing personal data assistants, personal LLM agents for automated content generation and scheduling management, and personal IoT network devices for enhanced social graph updates. Privacy management modules ensure HIPAA compliance while enabling user-controlled sharing of medication milestones and treatment achievements. Support group coordination modules facilitate virtual meetings and peer communications, while notification customization modules provide personalized updates for family members and caregivers based on detected medication administration events.

METHOD OF AND SYSTEM FOR DETERMINING AND CUSTOMIZING MEDICATION DELIVERY BASED ON MEDICATION SENSITIVITY

Publication No.:  AU2025231452A1 27/08/2026
Applicant: 
DEKA PRODUCTS LP
DEKA PRODUCTS LIMITED PARTNERSHIP
AU_2025231452_PA

Absstract of: AU2025231452A1

Disclosed is a method of determining sensitivity by a patient to a medication delivered at a delivery frequency including perturbing the delivery amount by a perturbation amount at a perturbation frequency, defining a perturbation signal, measuring a patient response to the perturbation, and recovering the effect of the perturbation. Also disclosed is a system for determining sensitivity by a patient to a medication including a processor configured for the method.

AN ORTHOPAEDIC IMPLANT

Publication No.:  WO2026175863A1 27/08/2026
Applicant: 
LOCATE BIO LTD [GB]
LOCATE BIO LIMITED
WO_2026175863_A1

Absstract of: WO2026175863A1

The present invention relates to a 3D-printed orthopaedic implant (201, 301, 401) comprising a non-porous support portion (205, 305, 405) and a porous osteoconductive scaffold (203, 303, 403), wherein the porous osteoconductive scaffold forms at least 60% of the volume of the 3D-printed orthopaedic implant, and the 3D-printed orthopaedic implant comprises at least one discrete hollow tunnel (207a-e, 307a-c, 407a-c) extending into the osteoconductive scaffold, each discrete hollow tunnel being independently configured to allow insertion of a solid osteoinductive filament (101a, b) therein, and wherein each discrete hollow tunnel independently has: a volume of 7% or less of the 3D-printed orthopaedic implant; a substantially uniform cross-section; and a length that is at least three times greater than its width. A solid osteoinductive filament operable to be introduced into the 3D-printed orthopaedic implant, and a kit formed therefrom, are also encompassed.

SYSTEMS AND METHODS FOR SUPPORTING ASSEMBLY OF A COLLECTION OF OBJECTS

Publication No.:  WO2026176339A1 27/08/2026
Applicant: 
EVIDONE SA [CH]
EVIDONE SA
WO_2026176339_A1

Absstract of: WO2026176339A1

The present disclosure provides automated systems and methods for supporting assembly of a collection of objects used for a task. In certain embodiments, the systems and methods support assembly of surgical trays for use in a surgical or other medical setting. A method may comprise receiving images from a camera. The images may be analyzed to automatically identify objects in the images and to automatically determine that the objects have been placed in a container. A container inventory corresponding to a task for the container may be updated that the objects have been placed in the container. Machine vision modules and checking a weight of a container may both aid in determining whether the objects have been placed in the container. Thus, the method may automate the process of assembly of a collection of objects that may lead to a reduction of errors.

TECHNOLOGY-DRIVEN MEDICATION MANAGEMENT SYSTEM FOR THE SECURE PERSONALIZED ASSOCIATION OF MEDICINES TO PATIENTS

Publication No.:  US20260253274A1 27/08/2026
Applicant: 
MEDGENIE AG [CH]
MEDGENIE AG
US_20260253274_A1

Absstract of: US20260253274A1

0000 A technology-driven medication management system and method for the secure dispensing of prescription and other medicines to patients, which in particular tailored to the patient's genetic data, which is easy to use is disclosed. This is reached by using special medication AR-label fixed to packages of medication products which are designed to be easily scanned by a mobile electronic device's camera module, providing immediate access to essential information such as dosage instructions and known side effects via an external server of a healthcare provider for each patient.

MANUALLY ROTATED MEDICAL IMAGING SYSTEMS AND ASSOCIATED METHODS

Publication No.:  WO2026178497A1 27/08/2026
Applicant: 
PULMERA INC [US]
PULMERA, INC.
WO_2026178497_A1

Absstract of: WO2026178497A1

Systems, methods, and devices for medical imaging are disclosed herein. In some embodiments, a method for imaging an anatomic region includes receiving, from a detector carried by an imaging arm of a mobile C-arm apparatus, a plurality of 2D images of the anatomic region. The images can be obtained during a non-isocentric manual rotation of the imaging arm. The method can also include receiving data indicative of a plurality of poses of the imaging arm during the manual rotation. The method can further include generating, based on the 2D images and the data, a 3D reconstruction of the anatomic region.

PHYSIOLOGIC RESPONSE MONITOR MOUTH WEARABLE

Publication No.:  US20260248442A1 27/08/2026
Applicant: 
UNIV OF SOUTH FLORIDA [US]
UNIVERSITY OF SOUTH FLORIDA
US_20260248442_A1

Absstract of: US20260248442A1

0000 Various components, methods, and systems are provided herein for monitoring physiological responses associated with force-impact events using a mouth-wearable sensing device positioned within an oral cavity of a subject. In some embodiments, the device integrates inertial sensing, force sensing, temperature sensing, and optical physiological sensing on a compact intraoral substrate and transmits physiological data wirelessly to an external computing device for analysis and reporting. In some embodiments, the mouth-wearable sensing device is customized using intraoral scan data to generate a three-dimensional oral cavity model and to position one or more sensors to align with anatomical landmarks when worn.

INFORMATION PROCESSING DEVICE, IMAGE GENERATION METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM

Publication No.:  US20260253275A1 27/08/2026
Applicant: 
NEC CORP [JP]
NEC SOLUTION INNOVATORS LTD [JP]
NEC Corporation
NEC Solution Innovators, Ltd.
US_20260253275_A1

Absstract of: US20260253275A1

An information processing device includes a digitizing unit for generating numerical data indicating a time-series change of a biological signal from first image data indicating a waveform of the biological signal, and an image generation unit for generating second image data indicating a waveform of the biological signal by using the generated numerical data. The generated second image data can be used as training data for machine learning or can be used for decision making by a medical worker in diagnosis of a subject to be measured for the biological signal.

ALLERGEN TEST PATCHES FOR AUTOMATED ALLERGIC CONTACT DERMATITIS PATCH TESTING

Publication No.:  WO2026178496A1 27/08/2026
Applicant: 
MAYO FOUND MEDICAL EDUCATION & RES [US]
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
WO_2026178496_A1

Absstract of: WO2026178496A1

An allergen test patch includes a patch substrate having a top surface and a bottom surface, at least one allergen well coupled to the bottom surface of the patch substrate, and a border removably coupled to and surrounding the patch substrate. The border has a top surface and a bottom surface. An adhesive is disposed on the bottom surface of the border to adhere the border to a skin surface of a subject, thereby removably coupling the patch substrate to the skin surface of the subject. When the border is adhered to the skin surface of the subject, removing the patch substrate from the border retains the border on the skin surface of the subject. This design allows for improved allergen testing by maintaining a defined test area on the skin after removal of the allergen-containing substrate.

AI-DRIVEN MEDICAL INTAKE ASSISTANT

Publication No.:  US20260253714A1 27/08/2026
Applicant: 
WYNK HEALTH INC [US]
Wynk Health, Inc.
US_20260253714_A1

Absstract of: US20260253714A1

An AI-driven medical intake assistant system includes a computing device having a processor and memory configured to execute an intake module, an abnormality detection module, and an electronic health record (EHR) integration module. The intake module presents a conversational interface that dynamically selects patient intake questions using a rule-based branching decision tree with clinical topic tags and transition rules. One or more connected diagnostic devices automatically capture patient vital sign measurements, including blood pressure, temperature, pulse oximetry, or weight, and transmit the measurements to the computing device. The abnormality detection module compares captured measurements to predefined threshold values or historical baseline data retrieved from the EHR and generates provider-facing alerts when deviation thresholds are exceeded. The EHR integration module maps patient responses and vital sign measurements into predefined structured EHR fields prior to a provider consultation.

ELECTROCARDIOGRAM EVALUATION USING Z-SCORE BASED STANDARDS

Nº publicación: US20260248436A1 27/08/2026

Applicant:

BRATINCSAK ANDRAS [US]
BRATINCSAK Andras

US_20260248436_A1

Absstract of: US20260248436A1

0000 Embodiments include an automated non-invasive method of assessment of an examined subject utilizing an electrocardiogram (ECG) system including: an electronic unit configured to connect to the examined subject, a memory unit configured to contain a database of Z-score-based nomograms of a first set of ECG variables from historic data of healthy individuals, a computer interface system, an adaptive confirmatory enhancement (ACE) module connected to various machine learning algorithms, an oversAIght module with artificial intelligence determining which algorithm to use, and a report generator, the method comprising: determining, by the computer interface system of the ECG system, a disease diagnosis of the examined subject based on a determination that the digital ECG values of the second set of ECG variables of the examined subject are abnormal.

traducir